Future Implications of Combination Regimens and Treatment Duration in CLL/SLL

Opinion
Video

Following recent updates from the SEQUOIA Arm D and CAPTIVATE studies, Mazyar Shadman, MD, MPH, discusses the future implications of fixed-duration therapy for patients with CLL/SLL.

Video content above is prompted by the following questions:

  • What are the future implications of fixed-duration therapy for patients with CLL/SLL?
    • What are the implications of the SEQUOIA Arm D and CAPTIVATE studies for this therapeutic approach?
Recent Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content